Related Experiment Video
Updated: May 21, 2025
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
POLR3-Related Leukodystrophy: A Qualitative Study on Parents' Experiences With the Health Care System
Adam Le1, Kelly-Ann Thibault2, Pouneh Amir Yazdani2
1Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada.
Insights
Parents of children with POLR3-related hypomyelinating leukodystrophy (POLR3-HLD) face significant challenges navigating healthcare. Improving access to specialized care and resources is crucial for these families managing a rare neurodegenerative disorder.
Area of Science:
- Neuroscience
- Genetics
- Rare Diseases
Background:
- POLR3-related hypomyelinating leukodystrophy (POLR3-HLD), also known as 4H leukodystrophy, is a rare inherited neurodegenerative disorder impacting central nervous system white matter development.
- Characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism, POLR3-HLD necessitates complex, specialized care.
- Due to the condition's rarity and limited awareness, affected families often become primary experts and advocates.
Purpose of the Study:
- To investigate the healthcare experiences of parents managing POLR3-HLD.
- To identify barriers and challenges in accessing care for POLR3-HLD patients.
- To pinpoint areas for improvement in healthcare delivery for rare neurodegenerative disorders.
Main Methods:
- Conducted semi-structured interviews with 24 parents of POLR3-HLD patients internationally.
- Focused interview questions on the diagnostic journey, care accessibility, and perceived quality of care.
- Employed reflexive thematic analysis on transcribed interviews to identify key themes in parental experiences.
Main Results:
- Identified four major themes: barriers to care access, knowledge gaps in diagnosis/care, parents acting as experts/advocates, and the benefit of specialized leukodystrophy care.
- Parents reported feelings of isolation, uncertainty, and a lack of guidance.
- Specialty clinics and expert care provided comfort and improved perceived quality of care.
Conclusions:
- Findings highlight critical needs for enhanced healthcare support systems for POLR3-HLD families.
- Informing providers, administrators, and policymakers to improve access to quality care is essential.
- Conclusions may offer insights applicable to improving care for other rare diseases.
Background:
POLR3-related hypomyelinating leukodystrophy (POLR3-HLD) is a rare, inherited neurodegenerative disorder affecting white matter development of the central nervous system. This disorder is characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism (4H leukodystrophy). Patients with POLR3-HLD require complex and specialized care; however, due to its rarity and limited awareness, parents often assume additional roles as experts and advocates for their child(ren). We aimed to understand parents' experiences navigating the health care landscape and to identify potential targets for improvement.
Methods:
Research team members conducted semi-structured interviews with parents of patients with POLR3-HLD. Interview questions focused on the diagnostic odyssey, availability and access to care, and the perceived quality of care. Interviews were recorded, transcribed, coded, and analyzed using reflexive thematic analysis, and themes surrounding parents' health care experiences were developed.
Results:
Nineteen semi-structured interviews were conducted with an international cohort of 24 parents between March and October 2023. Four themes were developed: existing barriers in accessing care, limited knowledge in diagnosis and care, parents as experts and advocates of their child(ren)'s care, and perceived superior care by leukodystrophy specialists. Many parents expressed feeling alone and uncertain, with little guidance provided to them. They also identified perceived gaps in care and challenges faced but found comfort when treated by leukodystrophy experts in specialty clinics.
Conclusions:
This study will help better inform health care providers, administrators, and policymakers to expand and improve access to quality care for patients with POLR3-HLD and their families. These conclusions may also be generalizable to other rare diseases.
Related Concept Videos
01:22Lysosomal Hydrolases
01:35Pedigree Analysis